Changing Diabetes® World Tour

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT01437072

INS-3934

U1111-1123-4683 (Other Identifier)

Details and patient eligibility

About

This study is conducted in the Middle East, Northern Africa and Europe. The aim of this study is to contribute to the design of a simple screening strategy for countries in scope, by exploring the association between risk factors and undiagnosed diabetes in a screening study.

Enrollment: 8,304 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Informed consent obtained

Exclusion criteria

• Subjects with known diabetes (exception: women with a history of gestational diabetes should not be excluded)
• Pregnant women or women who have given birth within less than a month
• Subjects suffering from severe illness
• Subjects with the inability to read and understand the information given (either due to illiteracy or vision problems) and therefore unable to give an informed consent
• Subjects with mental impairment
• Subjects treated with systemic cortico-steroids

Trial design

8,304 participants in 1 patient group

Total study population

Treatment:

Other: No treatment given